Brain Glioma Registry Combining Clinical and Imaging Information

Recruiting now

Conditions studied: Adult Glioma

In brief

This registry aims to collect clinical and radiologic information including detailed clinical, conventional MR and advanced MR imaging data of patients with brain gliomas. Advanced MR imaging may include diffusion-weighted imaging, perfusion-weighted imaging (dynamic susceptibility contrast, arterial spin labeling, dynamic contrast enhancement), and chemical exchange saturation transfer (CEST) imaging. This registry will describe course of disease and long-term outcomes of brain gliomas.

Key facts

Study ID

NCT02619890

Run by

Asan Medical Center

People needed

9000

Starts

2015-09-01

Expected to finish

2040-12-01

Last updated by the study team

2024-05-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have radiologically and histologically confirmed diagnosis of Brain Glioma
• Life expectancy of greater than 3 months
• Must receive a first- or second-line therapy
• Signed informed consent

You may not qualify if…

• No brain gliomas
• Patients who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulates, electronic infusion pumps, etc), because such devices may be displaced or malfunction
• Patients who are pregnant or breast feeding; urine pregnancy test will be performed on women of child bearing potential

Where it is running

• Asan Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.